Medication Management for Children with Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), and Behavioral Issues

Current Treatment Evaluation

The American Academy of Child and Adolescent Psychiatry recommends risperidone for treating irritability, aggression, and hyperactivity in children with ASD, with the current dose of 1mg nightly appearing effective for improving sleep and reducing evening behavioral issues while addressing appetite concerns 1, 3
Previous failed trials with guanfacine and clonidine were likely due to inadequate dosing or formulation issues rather than true lack of efficacy, in children with ASD and ADHD 1, 4
Stimulant medications worsened behavioral problems in some children with ASD, which is consistent with the known potential for stimulants to exacerbate behavioral issues in this population 3

The American Academy of Child and Adolescent Psychiatry suggests maintaining risperidone 1mg nightly as it provides benefit for sleep, evening behavior, and appetite in children with ASD and ADHD 1, 2
Risperidone has demonstrated efficacy for both irritability/aggression and hyperactivity in children with ASD, with studies showing significant improvement in both symptom domains 3, 2
Regular monitoring is essential for weight gain and metabolic effects, sedation/somnolence, and prolactin levels in children on risperidone 2, 5

Consider a retrial of extended-release guanfacine or extended-release clonidine for residual ADHD symptoms in children with ASD, starting with low doses and titrating slowly 1, 6
These medications have FDA approval as adjunctive therapy with other ADHD treatments, and extended-release formulations may provide better tolerability and efficacy than immediate-release versions 6, 4

Avoid reintroduction of stimulants given the previous behavioral worsening in children with ASD and ADHD 3
The combination of risperidone with a stimulant has shown benefit in some studies, but given the child's previous adverse reaction to stimulants, this approach is not recommended 1, 3
Risperidone's effect on hyperactivity may be sufficient without adding another medication, particularly if behavioral symptoms are the primary concern in children with ASD and ADHD 1, 3

Regular assessment of height, weight, and BMI is recommended every 3 months for children on risperidone 2
Monitor blood pressure and pulse, particularly if an alpha-2 agonist is added, and consider baseline and periodic metabolic monitoring 4, 2
Evaluate sleep quality, appetite, and behavioral symptoms at each visit, and reassess medication needs as the child develops, with the goal of using the minimum effective dose 2, 1